PHM4 COSTS AND CONSEQUENCES OF INADEQUATE COMPLIANCE WITH DEFEROXAMINE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA
May 1, 2006, 00:00 AM
10.1016/S1098-3015(10)64750-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64750-X/fulltext
Section Title :
Section Order :
166
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64750-X&doi=10.1016/S1098-3015(10)64750-X